Comera Life Sciences Holdings, Inc. (CMRA) DCF Valuation

Comera Life Sciences Holdings, Inc. (CMRA) DCF Valuation
  • Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • Professional Design: Trusted, Industry-Standard Templates
  • Pre-Built For Quick And Efficient Use
  • No Expertise Is Needed; Easy To Follow

Comera Life Sciences Holdings, Inc. (CMRA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our (CMRA) DCF Calculator empowers you to evaluate Comera Life Sciences Holdings, Inc. valuation using real-time financial data, offering complete flexibility to modify all essential parameters for improved projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
FY1
2023
FY2
2024
FY3
2025
FY4
2026
FY5
2027
Revenue .4 .3 .6 .9 1.2 1.6 2.1 2.8
Revenue Growth, % 0 -27.79 97.95 35.08 35.08 35.08 35.08 35.08
EBITDA -2.0 -5.4 -17.9 -.9 -1.2 -1.6 -2.1 -2.8
EBITDA, % -460.08 -1676.81 -2825.23 -100 -100 -100 -100 -100
Depreciation .1 .1 .1 .2 .2 .3 .4 .6
Depreciation, % 20.26 27.77 14.84 20.96 20.96 20.96 20.96 20.96
EBIT -2.1 -5.5 -18.0 -.9 -1.2 -1.6 -2.1 -2.8
EBIT, % -480.34 -1704.58 -2840.07 -100 -100 -100 -100 -100
Total Cash .2 6.5 .4 .6 .8 1.1 1.4 2.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .1 .2 .0
Account Receivables, % 26.02 69.27 5.42
Inventories .0 .0 .0 .0 .0 .0 .0 .1
Inventories, % 4.95 0.62533 0 1.86 1.86 1.86 1.86 1.86
Accounts Payable .1 .4 1.5 .6 .9 1.2 1.6 2.1
Accounts Payable, % 22.04 130.36 230.34 74.01 74.01 74.01 74.01 74.01
Capital Expenditure .0 -.1 .0 -.1 -.2 -.3 -.4 -.5
Capital Expenditure, % -2.79 -44.4 -4.52 -17.24 -17.24 -17.24 -17.24 -17.24
Tax Rate, % 0 0 0 0 0 0 0 0
EBITAT -2.1 -5.3 -18.0 -.8 -1.1 -1.5 -2.1 -2.8
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -2.1 -5.1 -16.7 -1.9 -1.0 -1.3 -1.8 -2.4
WACC, % 4.45 4.32 4.45 4.41 4.41 4.41 4.41 4.41
PV UFCF
SUM PV UFCF .0 .0 .0 .0 .0 .0 .0 -7.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -2
Terminal Value -103
Present Terminal Value -83
Enterprise Value -90
Net Debt 0
Equity Value -91
Diluted Shares Outstanding, MM 10
Equity Value Per Share -8.66

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real CMRA financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Quickly observe the impact of your inputs on Comera Life Sciences' valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Comprehensive CMRA Data: Pre-filled with Comera Life Sciences' historical financials and future growth projections.
  • Fully Customizable Inputs: Modify revenue growth rates, profit margins, discount rates, tax percentages, and capital expenditures.
  • Dynamic Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your customized inputs.
  • Scenario Testing: Develop various forecast scenarios to evaluate different valuation outcomes.
  • User-Friendly Design: Intuitive, organized, and crafted for both industry professionals and newcomers.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Comera Life Sciences Holdings, Inc.'s (CMRA) pre-filled financial data and forecasts.
  3. Step 3: Modify critical inputs like revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Watch the DCF model update instantly as you tweak assumptions.
  5. Step 5: Analyze the outputs and use the results for investment decisions.

Why Choose Comera Life Sciences Holdings, Inc. (CMRA)?

  • Innovative Solutions: Cutting-edge technology tailored for the life sciences industry.
  • Enhanced Efficiency: Streamlined processes that save time and resources for your projects.
  • Data-Driven Insights: Leverage reliable analytics to make informed decisions.
  • Customizable Services: Flexible options to meet your specific research and development needs.
  • Expert Support: A dedicated team of professionals committed to your success.

Who Should Use This Product?

  • Investors: Assess Comera Life Sciences Holdings, Inc.’s (CMRA) valuation prior to making investment decisions.
  • CFOs and Financial Analysts: Enhance valuation methodologies and evaluate financial forecasts.
  • Startup Founders: Discover how leading biotech firms like Comera are valued in the market.
  • Consultants: Create comprehensive valuation reports for your clientele.
  • Students and Educators: Utilize current market data to learn and teach valuation strategies.

What the Template Contains

  • Pre-Filled DCF Model: Comera Life Sciences' financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Comera Life Sciences' profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.